Long-term follow-up of rheumatoid arthritis patients who reached remission
Follows people with rheumatoid arthritis in remission to study long-term treatment and follow-up plans.
Plain-language title generated from the registry record
Registry title: Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission
Key facts
- Where
- Ålesund, Bergen, Drammen, Kristiansand, Lillehammer, Mo i Rana, Moss, Oslo, Sandvika, and Tromsø, NorwaySee the 10 sites
Where in Norway
- Ålesund HospitalÅlesund, NorwayNo longer taking part
- Haukeland University HospitalBergen, NorwayNo longer taking part
- Vestre Viken HospitalDrammen, NorwayNo longer taking part
- Sørlandet hospitalKristiansand, NorwayNo longer taking part
- RevmatismesykehusetLillehammer, NorwayNo longer taking part
- Helgelandssykehuset Mo i RanaMo i Rana, NorwayNo longer taking part
- Østfold HospitalMoss, NorwayNo longer taking part
- Diakonhjemmet HospitalOslo, NorwayNo longer taking part
- Martina Hansens HospitalSandvika, NorwayNo longer taking part
- University Hospital of North NorwayTromsø, NorwayNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Diakonhjemmet Hospital
- Trial code
- NCT06783322
- Record updated
- 10 March 2025
- Original description
The goal of this multi-center prospective observational study is to develop knowledge on how to best personalize treatment and follow-up strategies for patients with RA in remission, with the intention to prevent relapse of disease activity and progression of joint damage and at the same time avoid the use of unnecessary treatment and health resources.Read full original descriptionShow less
The ARCTIC REWIND Extension Study - Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission
The goal of this multi-center prospective observational study is to develop knowledge on how to best personalize treatment and follow-up strategies for patients with RA in remission, with the intention to prevent relapse of disease activity and progression of joint damage and at the same time avoid the use of unnecessary treatment and health resources.
The investigators will perform an extensive evaluation of all patients who participated in the ARCTIC REWIND study 10 and 15 years after they achieved sustained remission and received different treatment strategies.
Inclusion: Participation in the ARCTIC REWIND trial; Patients able and willing to give written informed consent and comply with the requirements of the study protocol.
Exclusion: Psychiatric or mental disorders, alcohol abuse, other substance abuse, other factors making adherence to the study protocol impossible.